Teams now span multiple states or even countries, complicating traditional group health coverage perks. A single regional network or state-specific option may not cover nomadic workers who fall outside the

As health tech startups race to prove value and scale, investors are tracking how pricing, adoption and workforce dynamics are reshaping the market. During an interview Tuesday at the ViVE

Migraine treatment took a leap forward with CGRP inhibitors, a drug class that has progressed from novel medicines to first-line therapies over the past decade. But there’s still an unmet

The Department of Justice and the state of Ohio filed an antitrust lawsuit against OhioHealth this week, alleging the health system used “all-or-nothing” contracting practices to force payers into include

Research shows that about one-third of caregivers experience depression or anxiety, and nearly half report experiencing significant caregiver burden. That’s why mental health company Headspace and online caregiver marketplace Care.com

Gilead Sciences is expanding its cell therapy pipeline and technological capabilities through the $7.8 billion acquisition of Arcellx, its partner in the development of a multiple myeloma treatment designed to

Let’s clear up a common misconception: when CMS audits a health plan, providers aren’t off the hook. In fact, the opposite is true. If you’re the one writing the notes,

More than 400 rural hospitals across the country are at risk of closure, battling a mix of reimbursement issues, workforce struggles and policy decisions that have left safety net providers

Hims & Hers is making a major global expansion with its planned acquisition of Australian digital health company Eucalyptus, a good move for the company as it faces regulatory and

Novartis is looking to build up its cardiovascular drug pipeline and it’s now partnering with Unnatural Products to support the effort. The pharmaceutical company is committing up to $100 million